WASHINGTON (AP) -- Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive drugs may be riskier than older drugs....
federal healthFDA favors more risk info on birth control pillsHeadlines from the Associated Press Tue, 12/06/2011 - 09:32
FDA issues warnings to 4 hand sanitizer companiesHeadlines from the Associated Press Wed, 04/20/2011 - 15:08
WASHINGTON (AP) -- Federal health regulators have issued warnings to four manufacturers of hand sanitizing products for making unsupported claims about the bacteria-fighting benefits of their products.... ONC Announces open public comment period on the Federal Health I...HHS News and Events Thu, 03/24/2011 - 23:01
The Office of the National Coordinator for Health Information Technology (ONC) today announced an open public comment period on the Federal Health IT Strategic Plan: 2011-2015 (“the Plan”). Tags:
Amgen bone drug OK'd for use in cancer patientsHeadlines from the Associated Press Thu, 11/18/2010 - 20:09
WASHINGTON (AP) -- Biotech drugmaker Amgen says federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in patients with advanced cancer.... FDA rejects highly-anticipated diet drug Qnexawashingtonpost.com - Health Thu, 10/28/2010 - 21:40
WASHINGTON -- Federal health regulators have decided not to approve an experimental diet pill called Qnexa, which had been touted by many experts as the most promising weight-loss drug in more than a decade. FDA panel backs anemia drugs for kidney diseaseHeadlines from the Associated Press Mon, 10/18/2010 - 14:43
ADELPHI, Md. (AP) -- Federal health advisers said Monday that patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.... FDA panel split on withdrawing diet pill MeridiaHeadlines from the Associated Press Wed, 09/15/2010 - 16:18
ADELPHI, Md. (AP) -- Federal health advisers delivered a split opinion Wednesday on whether to withdraw the diet pill Meridia due to evidence that it increases heart attack and stroke, with half voting to ban it and the others favoring new warnings and restricted distribution.... FDA warns of deadly side effect with imaging drugsHeadlines from the Associated Press Thu, 09/09/2010 - 12:54
WASHINGTON (AP) -- Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.... FDA panel mixed on approving Cymbalta for painHeadlines from the Associated Press Thu, 08/19/2010 - 12:29
WASHINGTON (AP) -- A majority of federal health advisers say a best-selling antidepressant from Eli Lilly & Co. appears effective in treating back pain, but not arthritis.... FDA warns of brain problem with Glaxo seizure drugHeadlines from the Associated Press Thu, 08/12/2010 - 11:11
WASHINGTON (AP) -- Federal health regulators are warning doctors and patients that an anti- seizure drug from GlaxoSmithKline can cause rare inflammation of the brain and spinal cord.... |
